<DOC>
	<DOCNO>NCT00723437</DOCNO>
	<brief_summary>Objective : Efficacy systemic retinoid therapy nail psoriasis never assess objectively . Evaluate therapeutic efficacy acitretin patient isolated nail psoriasis . Design : Open-study thirty-six patient moderate severe nail psoriasis treat acitretin . Participants : Patients include 27 men 9 woman ( mean age 41 ) nail psoriasis . Intervention : Therapy consist acitretin 0.2 0.3 mg/Kg/day 6 month . Main Outcome Measure ( ) : Clinical evaluation , NAPSI modify NAPSI score therapy , every 2 month therapy 6 month treatment .</brief_summary>
	<brief_title>Evaluation Efficacy Acitretin Therapy Nail Psoriasis</brief_title>
	<detailed_description>The Nail Psoriasis Severity Index ( NAPSI ) design successfully implement grade severity psoriatic nail disease . Moreover , utilization NAPSI score modify version severity index score instrument monitor response therapy recently document medical literature .This open study involve thirty-six patient moderate severe nail psoriasis treat low-dose acitretin January 2005 January 2007.Acitretin give dosage 0.2 0.3 mg/Kg/day 6 month . Laboratory investigation clinical evaluation , include photographic record score NAPSI modify NAPSI , perform every 2 month . Investigator evaluation perform use 0 ( improvement ) 3 ( clear almost clear ) score Treatment satisfaction patient tolerability assess visit . All patient follow least 6 month end treatment .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Acitretin</mesh_term>
	<criteria>patient moderate severe nail psoriasis premenopausal woman patient hepatic , renal metabolic diseases patient skin symptomatic arthropathic psoriasis previous systemic treatment nail psoriasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>nail , psoriasis , NAPSI , acitretin</keyword>
</DOC>